Deferred Income Tax Expense (Benefit) in USD of Dolby Laboratories, Inc. from 2010 to 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Dolby Laboratories, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from 2010 to 2025.
  • Dolby Laboratories, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 27 Dec 2024 was -$7.31M, a 35.4% decline year-over-year.
  • Dolby Laboratories, Inc. annual Deferred Income Tax Expense (Benefit) for 2025 was $4.99M.
  • Dolby Laboratories, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$21.6M, a 17.9% decline from 2023.
  • Dolby Laboratories, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$18.3M, a 37.8% increase from 2022.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)

Dolby Laboratories, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$7.31M -$1.91M -35.4% 28 Sep 2024 27 Dec 2024 10-Q 30 Jan 2025
Q4 2023 -$5.4M +$2.86M +34.6% 30 Sep 2023 29 Dec 2023 10-Q 30 Jan 2025
Q4 2022 -$8.26M +$749K +8.32% 01 Oct 2022 30 Dec 2022 10-Q 02 Feb 2024
Q4 2021 -$9M +$6.44M +41.7% 25 Sep 2021 31 Dec 2021 10-Q 02 Feb 2023
Q4 2020 -$15.4M -$6.27M -68.3% 26 Sep 2020 25 Dec 2020 10-Q 04 Feb 2022
Q4 2019 -$9.17M +$23.4M +71.8% 28 Sep 2019 27 Dec 2019 10-Q 29 Jan 2021
Q4 2018 -$32.6M -$65.3M -200% 29 Sep 2018 28 Dec 2018 10-Q 29 Jan 2020
Q4 2017 $32.7M +$36M 30 Sep 2017 29 Dec 2017 10-Q 01 Feb 2019
Q4 2016 -$3.28M +$7.21M +68.8% 01 Oct 2016 30 Dec 2016 10-Q 31 Jan 2018
Q4 2015 -$10.5M -$4.18M -66.2% 26 Sep 2015 01 Jan 2016 10-Q 02 Feb 2017
Q4 2014 -$6.31M -$4.99M -377% 27 Sep 2014 26 Dec 2014 10-Q 05 Feb 2016
Q4 2013 -$1.32M +$1.31M +49.7% 28 Sep 2013 27 Dec 2013 10-Q 30 Jan 2015
Q4 2012 -$2.63M +$5.02M +65.6% 29 Sep 2012 28 Dec 2012 10-Q 29 Jan 2014
Q4 2011 -$7.64M -$1M -15.1% 01 Oct 2011 30 Dec 2011 10-Q 06 Feb 2013
Q4 2010 -$6.64M 25 Sep 2010 31 Dec 2010 10-Q 03 Feb 2012

Dolby Laboratories, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $4.99M +$26.6M 28 Sep 2024 26 Sep 2025 10-K 18 Nov 2025
2024 -$21.6M -$3.28M -17.9% 30 Sep 2023 27 Sep 2024 10-K 18 Nov 2025
2023 -$18.3M +$11.1M +37.8% 01 Oct 2022 29 Sep 2023 10-K 18 Nov 2025
2022 -$29.5M +$7.58M +20.5% 25 Sep 2021 30 Sep 2022 10-K 19 Nov 2024
2021 -$37M -$31.8M -602% 26 Sep 2020 24 Sep 2021 10-K 17 Nov 2023
2020 -$5.27M +$34.9M +86.9% 28 Sep 2019 25 Sep 2020 10-K 18 Nov 2022
2019 -$40.2M -$101M -166% 29 Sep 2018 27 Sep 2019 10-K 17 Nov 2021
2018 $61.1M +$96.1M 30 Sep 2017 28 Sep 2018 10-K 16 Nov 2020
2017 -$35M -$12.2M -53.7% 01 Oct 2016 29 Sep 2017 10-K 25 Nov 2019
2016 -$22.8M -$8.31M -57.4% 26 Sep 2015 30 Sep 2016 10-K 15 Nov 2018
2015 -$14.5M -$7.79M -116% 27 Sep 2014 25 Sep 2015 10-K 16 Nov 2017
2014 -$6.7M +$12.9M +65.9% 28 Sep 2013 26 Sep 2014 10-K 18 Nov 2016
2013 -$19.6M -$20.9M -1726% 29 Sep 2012 27 Sep 2013 10-K 24 Nov 2015
2012 $1.21M -$5.58M -82.2% 01 Oct 2011 28 Sep 2012 10-K 18 Nov 2014
2011 $6.78M +$22.8M 25 Sep 2010 30 Sep 2011 10-K 15 Nov 2013
2010 -$16M 26 Sep 2009 24 Sep 2010 10-K 15 Nov 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.